Vertex Global Hc Fund Ii Pte. Ltd. is > 10% Shareholder of Elevation Oncology, Inc.. Currently has a direct ownership of 2.31 Million shares of ELEV, which is worth approximately $6.46 Million. The most recent transaction as insider was on Jun 29, 2021, when has been sold 250,000 shares (Common Stock) at a price of $16.0 per share, resulting in proceeds of $4,000,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.31M
0% 3M change
0% 12M change
Total Value Held $6.46 Million

Vertex Global HC Fund II Pte. Ltd. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 29 2021
BUY
Open market or private purchase
$4,000,000 $16.0 p/Share
250,000 Added 9.77%
2,307,642 Common Stock
Jun 29 2021
BUY
Conversion of derivative security
-
2,057,642 Added 50.0%
2,057,642 Common Stock
VGH

Vertex Global Hc Fund Ii Pte. Ltd.

> 10% Shareholder
Singapore, U0

Track Institutional and Insider Activities on ELEV

Follow Elevation Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ELEV shares.

Notify only if

Insider Trading

Get notified when an Elevation Oncology, Inc. insider buys or sells ELEV shares.

Notify only if

News

Receive news related to Elevation Oncology, Inc.

Track Activities on ELEV